Promoting Wedical innovation While Developing Sound Social And Bysiness Policy: A Conversation With Thomas Roberts-An oncologist turned financial adviser discusses some intersections between his two chosen professions: price, profit, and continued innovation.

摘要

The development of "targeted biologies" as cancer therapy has made the field ripe for investment from the private sector and is changing the face of cancer medicine, while also raising important policy concerns about price, profit, and continued innovation. In this interview Barbara Culliton talks with Thomas Roberts, who sees this world from a unique perspective. Roberts, an oncologist, has practiced at the Massachusetts General Hospital and is currently thinking about innovation as a hedge fund manager.